1. Home
  2. NBTX vs LILAK Comparison

NBTX vs LILAK Comparison

Compare NBTX & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$37.81

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Latin America Ltd. Class C

LILAK

Liberty Latin America Ltd. Class C

HOLD

Current Price

$7.44

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTX
LILAK
Founded
2003
2017
Country
France
Bermuda
Employees
N/A
9000
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NBTX
LILAK
Price
$37.81
$7.44
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$36.00
$8.20
AVG Volume (30 Days)
67.4K
1.9M
Earning Date
03-31-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$58.17
$1.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.79
$4.75
52 Week High
$57.14
$9.13

Technical Indicators

Market Signals
Indicator
NBTX
LILAK
Relative Strength Index (RSI) 51.60 51.75
Support Level $30.15 $4.75
Resistance Level $38.29 $8.71
Average True Range (ATR) 2.46 0.47
MACD 0.45 0.17
Stochastic Oscillator 67.69 77.94

Price Performance

Historical Comparison
NBTX
LILAK

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: